News

The committee also said that girls as young as nine should receive the vaccine at the discretion of doctors. Gardasil is designed to prevent the majority of human

The trial is being initiated following FDA and central institutional review board (IRB) approval of the trial protocol. The study builds on the observation of prolonged stable disease

Cipher’s Cip-Tramadol ER new drug application (NDA) contains data from six completed pharmacokinetic studies and five phase III studies with three of these providing pivotal efficacy data and

In addition to milestone and royalty payments to be paid to Nabi Biopharmaceuticals, Kedrion will assume development costs for the product candidate in both Europe and the US

Under the terms of the agreement, KineMed will apply its proprietary technologies to find alternative applications for discontinued compounds formerly in Organon’s clinical-stage pipeline. Once therapeutic utility is

Upon clearance by the regulator, Lexicon intends to initiate a phase I clinical trial of LX6171 in healthy volunteers to assess the compound’s safety, tolerability and pharmacokinetics. In

It is hoped that patients treated with Miraxion at a dose of 2g per day (1g twice daily) for six months will demonstrate significant improvements in their motor

Since receiving approval to initiate the study in the UK recently, the first three patients have been treated. Pharmos expects to complete the trial in the third quarter

Hypogonadism is a condition that is estimated to affect approximately 20% of the US male population over age 50. It is characterized by reduced or deficient secretion of